M L Plunkett

The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3

Periasamy Selvaraj, M L Plunkett, Michael L. Dustin et al. · Nature · 1987 · 448 citations

Autoimmune Disease, Immune Regulation, Immunology +9

A non–RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis <i>in vivo</i>

Parisa Khalili, Ani Arakelian, Gaoping Chen et al. · Molecular Cancer Therapeutics · 2006 · 196 citations · Full text

Calcium alginate beads as a slow‐release system for delivering angiogenic molecules In Vivo and In Vitro

Elizabeth C. Downs, Nancy E. Robertson, Terry Riss et al. · Journal of Cellular Physiology · 1992 · 146 citations

Angiogenesis blockade as a new therapeutic approach to experimental colitis

Silvio Danese, Miquel Sans, David M. Spencer et al. · Gut · 2006 · 126 citations · Full text

Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3).

M L Plunkett, Martin E. Sanders, Periasamy Selvaraj et al. · The Journal of Experimental Medicine · 1987 · 123 citations · Full text

Ligand Molecules, Lymphocyte Development, Cell Adhesion +23